Business Information
The company's principal activity is the development, manufacture and marketing of radiological pharmaceuticals and devices used in the treatment of cancer. The company's product, theraseed, is an implantable radiation device used primarily in the treatment of prostate cancer. The company has developed therasphere, a microscopic glass sphere, which is used for the treatment of liver cancer. It is also involved in the research and development using pd-103 for the treatment of restenosis, macular degeneration and other diseases and programs involving other isotopes and their uses. The company's customers include physicians, hospitals and other healthcare providers.
|
|
Name |
Title
|
Email
|
| Christine Jacobs | Chmn., CEO, Pres. | N/A | | James Eddings | Pres. - Galt Medical Corp | N/A | | Michael Lang | Pres. - Galt Medical | N/A | | Patrick Ferguson | Pres. - CP Medical | N/A | | Francis Tarallo | CFO, Treasurer | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 54,096 | 6,865 | | 2005 | 44,270 | (29,006) | | 2004 | 33,338 | (4,310)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
